| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in LQDA over the last quarter tilts toward selling: insiders offloaded a net 389,884 shares worth roughly $27.8M. In the past 30 days, 0 insiders bought and 9 sold.
On the other side, 9 insiders reduced their position over the period. LQDA sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.13M | $746.02M | - | |
| CEO | 1.16M | $106.69M | -35,249 | |
| Dir | 701.5K | $64.34M | -78,596 | |
| Other | 606.0K | $55.58M | -14,738 | |
| Dir | 469.6K | $43.07M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 29, 2024 | Moomaw Scott | Chief Commercial Officer | Sale+OE | 546 | $14.17 | $7,736.82 | -0.3% | -12.3% | +9.4% | |
| Feb 29, 2024 | Adair Jason | Chief Business Officer | Sale+OE | 455 | $14.17 | $6,447.35 | -0.5% | -12.3% | +9.4% | |
| Dec 18, 2023 | Adair Jason | Chief Business Officer | Sale+OE | 77 | $7.70 | $592.90 | -0.1% | +108.4% | +51.5% | |
| Dec 18, 2023 | Saggar Rajeev | Chief Medical Officer | Sell | 14,887 | $7.42 | $110,461.54 | -8.3% | +108.4% | +51.5% | |
| Dec 14, 2023 | Jeffs Roger64 | Chief Executive Officer | Buy | 139,665 | $7.16 | $1,000,001.40 | +27.9% | +102.1% | +49.8% | |
| Dec 14, 2023 | Caligan Partners LP58 | Director, 10% Owner, See Remarks | Buy | 1,117,318 | $7.16 | $7,999,996.88 | +11.0% | +102.1% | +49.8% | |
| Dec 14, 2023 | Manning Paul B54 | Director | Buy | 279,330 | $7.16 | $2,000,002.80 | New | +102.1% | +49.8% | |
| Nov 30, 2023 | Lippe Robert A54 | Chief Operations Officer | Sale+OE | 497 | $7.28 | $3,618.16 | -0.3% | +100.9% | +61.3% | |
| Nov 30, 2023 | Moomaw Scott | Chief Commercial Officer | Sale+OE | 542 | $7.28 | $3,945.76 | -0.5% | +100.9% | +61.3% | |
| Nov 30, 2023 | Adair Jason | Chief Business Officer | Sale+OE | 452 | $7.28 | $3,290.56 | -0.8% | +100.9% | +61.3% |